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Background: An interview format version of the Sheehan Disability Scale (SDS) modified to assess gambling
treatment outcomes was assessed for reliability and validity. The SDS assesses impairment in work, family and social
functioning related to mental disorders.
Methods: A pilot study (N = 21) determined the preferred wording for oral administration. Participants with
pathological gambling in a relapse prevention clinical trial completed the scale and other validation measures at
baseline, six and twelve month follow-ups (N = 169).
Results: Confirmatory factor analysis supported a one factor solution and the scale had good internal reliability for
a three item scale. The SDS was sensitive to change and correlations with recent gambling behaviour and severity
were moderate as expected. Similarly, correlations with self-efficacy, perceived control over gambling, and craving
were moderate, but they were lower for less directly related constructs such as depression and perceived family
and friend support.
Conclusions: The SDS is a brief, psychometrically sound, outcome measure of impairment associated with
gambling disorders that can be administered by telephone.
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The Sheehan Disability Scale (SDS) was originally
designed to assess functional impairment associated with
anxiety disorder diagnoses [1]. Functional impairment or
disability is related to, but conceptually distinct from,
symptom severity and distress. The SDS is a three-item
self-completion scale measuring the impact of symptom-
atology on work, social and family functioning. Because of
its simplicity, brevity, and high face validity, and because
of the lack of competing brief measures of functional
impairment, the SDS has become a widely used out-
come measure in clinical trials of a variety of mental
health disorders. The SDS has been used for obsessive
compulsive disorder, post-traumatic stress disorder,
major depressive disorder, panic disorder, social anxiety
disorder, schizophrenia [2] and, most recently, patho-
logical gambling [3-6]. As of 2007, the SDS had been
translated from English into 48 languages [2].Correspondence: dhodgins@ucalgary.ca
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reproduction in any medium, provided the orDespite its popularity, limited data on the psychomet-
ric properties of the SDS have been published. Leon,
Shear, Portera and Klerman [7] analyzed clinical trial
data obtained from patients with panic disorder. The au-
thors reported that the scale had adequate internal reli-
ability (α = .56 to .86) and a stable one factor structure
at baseline and post-treatment follow-up. They also
demonstrated that the measure is sensitive to treatment-
related change and that the scores, as expected, were
moderately associated with panic symptoms. Leon and
colleagues [8] also examined the SDS in a sample of pri-
mary care outpatients concurrently assessed for mental
health disorders. Internal reliability was excellent (α = .89)
and a one factor structure was also supported. In terms of
validity, patients who met the criteria for a mental dis-
order had more impairment than those who did not. The
authors used a cut-point of five or greater on the 30-point
scale, and they found that the SDS had good sensitivity
and specificity in identifying the mental disorder patients.
Sheehan and Sheehan [2] reviewed the use of the
scale in published clinical trials in order to establishThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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provide preliminary recommendations that a total score of
6 or less indicates remission and a score of 12 or less indi-
cates treatment response. A reduction of approximately 4
points indicates improvement [2].
In the gambling arena, a number of well validated
interview and self-rated measures of symptom severity
are available [9] including: the South Oak Gambling
Screen (SOGS) [10], the Problem Gambling Severity
Index (PGSI) of the Canadian Problem Gambling Index
[11,12], the National Opinion Research Centre DSM
Screen for Gambling Problems (NODS), [13], the Gambling
Symptom Assessment Scale [14], and the Gambling
Treatment Outcome Monitoring System [15]. Addition-
ally, interview measures of self-reported gambling be-
haviours (frequency, money and time spent) show good
psychometric properties [16,17]. Measures of impair-
ment include the SDS as well as a gambling adaptation
of the Addiction Severity Index (ASI-G), which is an
interview measure that assesses functioning and need for
treatment in a variety of domains including gambling
problems, physical health, employment, social relation-
ships, psychiatric functioning, alcohol and other drug use
and legal problems. The gambling subscale has been well
validated in treatment populations [18-20] whereas the
other subscales have been mostly validated with substance
abuse populations. The SDS has not been assessed psy-
chometrically despite its use.
The purpose of this report is to provide data on the
reliability and validity of an interview version of the
Sheehan Disability Scale modified for gambling (SDS-G).
Data from a trial of a distance relapse prevention pro-
gram were used to assessment the psychometric proper-
ties. One of the unique features of the SDS is that the
scale items are presented visually as a horizontal line
marked with both numbers (0 to 10) and verbal anchors
(0 = Not at all, 1–3 = mildly, 4–6 = moderately, 7–9 =
markedly, and 10 = extremely). The numbers are
presented in a larger font than the verbal anchors and
respondents are required to choose a specific number to
indicate their response. This design is easy for patients
to complete, but, unfortunately, limits the scale from be-
ing used in a face-to-face or telephone interview format.
Because telephone follow-up is often used in gambling
treatment studies, the first step in this investigation was
to solicit feedback from interviewers and respondents
with pathological gambling about the clarity of different
response options in an interview format. The response
options were modified from the instructions provided
for the self-completion version.
Methods
Ethical approval for this study was provided by the
Conjoint Faculties Ethic Review Board at the Universityof Calgary and all participants provided written informed
consent.
Examination of response options
Two experienced interviewers participated in this pilot
examination of response options. The pilot study was
conducted to determine the preferred wording for tele-
phone interviews. Participants (N=21) meeting the cri-
teria for pathological gambling, as part of a telephone
assessment, were informed by the interviewer that: “I
am going to ask you some questions regarding how your
gambling problem has affected your life in the past
month”. Participants where then asked two questions
about each of the three domains. The domains were
asked in the standard order used previously (work, social
and family), but question response order was random-
ized. For example: “To what extent has your gambling
disrupted your work or studies in the past month?
Would you say not at all, mildly, moderately, markedly,
or very severely? To what extent has your gambling
problem disrupted your work or studies in the past
month on a scale of 0 to 10, with zero indicating not at
all and 10 indicating severely?” Participant agreement
across the two response options was computed and the




For the trial of the distance relapse prevention program,
a sample of individuals meeting criteria for pathological
gambling (N = 169) was recruited through media an-
nouncements and was assessed via telephone [21].
Gambling outcomes included self-reported gambling
behaviours, confirmed by collateral reports, and gam-
bling problem severity. Assessments were conducted at
baseline, six weeks, six months and twelve months by
trained research assistants. Results indicated that ex-
tended versus brief support did not improve gambling
outcomes over 12 months.
Interview measures
The initial interview included: a gambling history meas-
ure including a timeline follow-back interview assessing
gambling behaviour [16]; two measures of gambling
problem severity (the NODS, which measures DSM-IV
criteria for the past year and lifetime [13] and the SOGS
[10]), which measures past year problem severity; a
measure of self-efficacy for quitting gambling (Gambling
Abstinence Self-efficacy Scale or GASS) [22]; a measure
of gambling craving over the past 24 hours [23]; a measure
of current depression (Centre of Epidemiologic Studies –
Depressed Mood Scale or CES) [24]; and the SDS-G.
Table 1 Means (SD) and Pearson correlations between
individual items and total scores at each assessment
Mean SD Range Work Social Family Total
Initial (N=46)
Work 1.7 3.0 0-10 - .17 .33 .62
Social 4.2 3.9 0-10 .40 .75
Family 5.4 3.8 0-10 .81
Total 11.4 7.9 0-30 -
Six months (N = 146)
Work 1.0 2.5 0-10 - .54 .48 .78
Social 1.5 2.9 0-10 .63 .86
Family 2.1 3.2 0-10 .86
Total 4.5 7.8 0-30 -
Twelve months (N=142)
Work 1.00 2.4 0-10 - .53 .52 .77
Social 1.6 2.8 0-10 .71 .88
Family 2.1 3.3 0-10 .90
Total 4.7 7.2 0-30 -
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were:
 To what extent has your gambling problem
disrupted your work or studies in the past month on
a scale of 0 to 10, with zero indicating not at all and
10 indicating extremely?
 To what extent has your gambling problem
disrupted your social life in the past month on a
scale of 0 to 10, with zero indicating not at all and
10 indicating extremely?
 To what extent has your gambling problem
disrupted your Family life/household responsibilities
in the past month on a scale of 0 to 10, with zero
indicating not at all and 10 indicating extremely?
The six month follow-up interviews included: a time-
line follow-back to capture gambling behaviour since the
last assessment; the GASS; the SDS-G; and a measure of
perceived control over gambling (0–10 point scale). The
twelve month assessments included: the instruments used
at six months plus the past-year versions of the NODS
and SOGS and a third measure of problem severity, the
PGSI; the CES; an unpublished six item past week gam-
bling craving measure; and a measure of perceived social
support provided by family and friends [25].
Analyses
Internal reliability was computed for baseline, six and
twelve month data. Confirmatory factor analysis, using
maximum likelihood structural equation modelling, was
computed using six and twelve month data. To maximize
sample size, baseline data were excluded and missing data
(6 cases at 12 months) were estimated using full informa-
tion maximum likelihood [26]. Model fit was assessed using
the χ2/df ratio, comparative fit index (CFI) and the root
mean square error of approximation (RMSEA). Criteria for
good fit was considered to be χ2/df ratio < 3.00 [27], CFI >
0.95 [28] and RMSEA < 0.05 [29]. Concurrent validity was
assessed with Pearson correlations between SDS-G scores
and measures of gambling behaviour, problem gambling se-
verity and self-efficacy at each assessment. Sensitivity to
change was assessed in two ways. Changes in SDS-G scores
over time were examined using one-way repeated measures
ANOVA. The association between change in SDS-G scores
and change in SOGS, days of gambling and depression
from baseline to the 12 month follow-up was examined
using Pearson correlations of difference scores. Analyses
were conducted using SPSS and AMOS V.19.
Results
Examination of response options
Intraclass correlation coefficients showed that the two
response options correlated strongly for each of thethree domains, work ICC = 0.95, social life ICC = 1.00,
family/home responsibilities ICC = 0.94. The two inter-
viewers preferred the 0 to 10 point scale option, indicat-
ing that it was easier to administer orally.
Psychometric examination
A total of 169 participants met the inclusion criteria for
this study. The SDS-G was administered after the trial
had already commenced; therefore, we did not have
baseline data for 113 participants. However, the final 56
participants recruited did complete the SDS-G at baseline.
All participants successfully followed at six (n = 146) and
twelve months (n = 142) completed the SDS-G. There
were no significant differences in baseline demographics
or gambling variables between participants who did
and did not complete the SDS-G at baseline or partici-
pants who were or were not followed at six and twelve
months [21].
Participant mean age was 42 years (SD = 11.2, range
21–65) and 42% were female. Most participants reported
problems with video lottery terminals (VLTs, 80%), slot
machines (38%) and casino games (20%). Participants
reported having had a gambling problem since the mean
of age 34 (SD = 11.2) and 60% had had previous treat-
ment or had attended Gamblers Anonymous. The mean
SOGS total was 11.3 (SD = 3.3) and the mean lifetime
NODS score was 8.6 (SD = 1.2).
Table 1 displays means (SD) and the Pearson correla-
tions between the individual items and total scores at each
assessment. Internal reliability was estimated at α = 0.56
at baseline, α = 0.78 at six months and α = 0.81 at 12
months. All three values are adequate for a three item
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partly due to the smaller sample size.
Figure 1 displays the one factor structure at six and
twelve months along with standardized coefficients. The
fit indices suggested excellent fit: χ2/df ratio = 1.30,
CFI = 0.99 and RMSEA = 0.044. The work variables
loaded slightly less strongly on the latent disability
constructs than family and social impairment items.
Table 2 displays Pearson correlations between gambling
behaviour and severity measures and measures of a num-
ber of other constructs such as depression and social sup-
port. Correlations with each of the three SDS-G items as
well as the total score are provided. Correlations with re-
cent gambling behaviour and severity were moderate as
expected. Similarly, correlations with self-efficacy and per-
ceived control over gambling and craving were moderate.
However, correlations with lifetime problem gambling
severity (NODS) were non-significant. This measure was
obtained at baseline and with a smaller sample size. Fi-
nally, SDS items and total correlated with depression and
perceived family and friend support.
In terms of sensitivity to change, SDS-G total scores
for individuals followed at all three assessments showed
a significant reduction from baseline (M = 10.5, SD =
8.0) compared to the six (M = 3.1, SD = 5.2) and twelve
month follow-up periods (M = 4.4, SD = 7.0; F (2, 41) =
15.3; p<0.0001; partial eta squared = 0.43). Change in
SOGS scores, days of gambling, and CES depression
scores from baseline to twelve month follow-up corre-
lated with changes in SDS-G scores at r = 0.54, 0.33,
and 0.53 respectively (p<0.0001).Figure 1 Confirmatory factor structure of the Sheehan Disability ScaleDiscussion
These analyses provide evidence in support of a gam-
bling modified SDS to assess gambling treatment out-
comes via interview. Because of the nature of the relapse
prevention study, this sample of pathological gamblers
includes a range of gambling involvements from abstin-
ent to heavy gambling, which is optimal in terms of
validating a scale. The results supported a one factor
solution and the scale had good internal reliability for a
three item scale. The SDS-G appears sensitive to change
and it appears to correlate more strongly with other
measures of current functioning than lifetime measures.
Future research should assess of retest reliability of the
scale and it would also be useful to assess concurrent
validity of the very brief scale against more lengthy
measures of functional impairment such as the Social
Adjustment Scale [30] and the Medical Outcome Study
SF-36 [31]; however, these scales have not been validated
for pathological gambling samples. Validation of a self-
completion version would also be valuable. Moreover,
some clinical trial studies report the individual item
scores in addition to the total scores. The reliability and
validity of individual items needs further examination. In
the structural equation model, the work variables loaded
less strongly on the latent disability construct than the
family and social variables and, similarly, the work vari-
able correlated less strongly with the SDS-G total (see
Table 1). The work variable also correlated less strongly
with the concurrent validity variables than did the social,
family and total scores (see Table 2). This difference may
be related to the fact that gambling problems have lessfor gambling over time.
Table 2 Pearson Correlations between SDS-G total and
items and external constructs
Work Social Family SDS-G
Total
Initial (N = 56)
NODS- lifetime .20n.s. .01 n.s. .18 n.s. .17 n.s.
NODS – past year .24 n.s. .16 n.s. .35 .34
SOGS – past year .36 .16 n.s. .51 .46
Days abstinent – prior to initial -.13 n.s. -.26 -.29 -.31
CES .15 n.s. .30 .20 n.s. .30
Six months (N = 146)
Perceived control -.47 -.47 -.48 -.58
GASS -.37 -.50 -.40 -.52
Days gambled – past month1 .26 .39 .32 .41
Twelve months (N = 142)
Perceived control -.21 -.41 -.44 -.43
GASS -.21 -.39 -.52 -.46
Days gambled – past month .26 .57 .49 .52
Craving .32 .52 .58 .59
NODS – past year .39 .51 .53 .56
SOGS – past year .39 .53 .56 .58
PGSI .35 .48 .50 .52
CES .34 .40 .50 .51
Family support -.13 n.s. -.22 -.27 -.27
Friend support -.22 -.27 -.35 -.33
Note. NODS NORC DSM Screen for Gambling, SOGS South Oaks Gambling
Screen, CES Centre of Epidemiologic Studies – Depressed Mood Scale, GASS
Gambling Abstinence Self-Efficacy Scale, PGSI Problem Gambling Severity
Index. All correlations significant except where indicated (ns=non-significant).
1n = 142.
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functioning is important to finance continued gambling
(see mean scores on Table 1), or it may indicate a
weaker measure of the work disability construct.
Although these analyses support the psychometric
strength of this brief scale, they do not provide validated
interpretation guidelines for improvement or adequate
social functioning. The existing guidelines are not dis-
order specific and are meant to be used for a variety of
disorders. Nonetheless, validation for each disorder indi-
vidually is crucial. Interpretation guidelines would increase
the practical utility of using this scale in outcome studies
as well as use by clinicians monitoring patent outcome.Conclusions
In conclusion, the SDS-G total score should work well
as an outcome measure that is correlated with both
gambling behaviour and gambling problem severity, but
also conceptually and statistically distinct. Despite itsbrevity, it shows good internal reliability, good evidence
of factorial validity and it is sensitive to patient changes.
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